VIRGINIA HANCOCK: Open Payments
NPI 1457750267 · NEW BERN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,195 in 62 payments from 13 companies in 2025. Trend: 2023 $763 · 2024 $1,002 · 2025 $1,195
Food & beverage: $1,113Education: $81
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $439 |
| AstraZeneca Pharmaceuticals LP | 4 | $217 |
| Teva Pharmaceuticals USA, Inc. | 6 | $170 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $136 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| Ardelyx, Inc. | 2 | $35 |
| Novo Nordisk Inc | 2 | $31 |
| PFIZER INC. | 2 | $28 |
| Astellas Pharma US Inc | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: VRAYLAR, BREZTRI, CAPLYTA, AUSTEDO XR, AIRSUPRA, REXULTI, IBSRELA, MAVYRET.
Industry payments across NC — which companies pay providers there.
